These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20631348)

  • 1. Increased coronary heart disease risk determined by high high-density lipoprotein cholesterol and C-reactive protein: modulation by variation in the CETP gene.
    Dullaart RP
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1502-3. PubMed ID: 20631348
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels.
    Corsetti JP; Ryan D; Rainwater DL; Moss AJ; Zareba W; Sparks CE
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1657-64. PubMed ID: 20489166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cholesteryl ester transfer protein I405V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: the Rotterdam Study.
    Isaacs A; Sayed-Tabatabaei FA; Hofman A; Oostra BA; Klungel OH; Maitland-Vander Zee AH; Stricker BH; Witteman JC; van Duijn CM
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):419-21. PubMed ID: 17568242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
    Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
    Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels.
    Corsetti JP; Ryan D; Moss AJ; McCarthy J; Goldenberg I; Zareba W; Sparks CE
    Thromb Haemost; 2011 Dec; 106(6):1170-8. PubMed ID: 22011848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP.
    Corsetti JP; Gansevoort RT; Navis G; Sparks CE; Dullaart RP
    Atherosclerosis; 2011 Feb; 214(2):373-6. PubMed ID: 21146168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P; Mensink RP; Hornstra G
    Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesteryl ester transfer protein TaqIB, -629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population.
    Padmaja N; Kumar RM; Balachander J; Adithan C
    Clin Chim Acta; 2009 Apr; 402(1-2):139-45. PubMed ID: 19168039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.
    Moriyama Y; Okamura T; Inazu A; Doi M; Iso H; Mouri Y; Ishikawa Y; Suzuki H; Iida M; Koizumi J; Mabuchi H; Komachi Y
    Prev Med; 1998; 27(5 Pt 1):659-67. PubMed ID: 9808796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction.
    Fumeron F; Betoulle D; Luc G; Behague I; Ricard S; Poirier O; Jemaa R; Evans A; Arveiler D; Marques-Vidal P
    J Clin Invest; 1995 Sep; 96(3):1664-71. PubMed ID: 7657837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.
    Seiler S; Schlitt A; Jiang XC; Ulrich C; Blankenberg S; Lackner KJ; Girndt M; Werdan K; Buerke M; Fliser D; Heine GH
    Nephrol Dial Transplant; 2008 Nov; 23(11):3599-604. PubMed ID: 18503096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
    Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesteryl ester transfer protein gene and coronary heart disease mortality: the Rotterdam study.
    Silva MC; Janssens AC; Hofman A; Witteman JC; van Duijn CM
    J Am Geriatr Soc; 2007 Sep; 55(9):1483-4. PubMed ID: 17767699
    [No Abstract]   [Full Text] [Related]  

  • 17. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
    Dullaart RP; Borggreve SE; Hillege HL; Dallinga-Thie GM
    Scand J Clin Lab Invest; 2008; 68(2):99-105. PubMed ID: 17852818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease.
    Zheng KQ; Zhang SZ; He Y; Zhang L; Zhang KL; Huang DJ; Sun Y
    Chin Med J (Engl); 2004 Sep; 117(9):1288-92. PubMed ID: 15377415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I405V and TaqIB polymorphisms of the cholesteryl ester transfer protein and their relation to serum lipid and lipoprotein levels in a Turkish population.
    Doğru-Abbasoğlu S; Parildar-Karpuzoğlu H; Depboylu B; Cine N; Uysal M; Aykaç-Toker G
    Cell Biochem Funct; 2009 Mar; 27(2):76-80. PubMed ID: 19165812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients.
    Yilmaz H; Isbir T; Agachan B; Karaali ZE
    Cell Biochem Funct; 2005; 23(1):23-8. PubMed ID: 15386541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.